Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function.
about
Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenalMyeloperoxidase-derived oxidants induce blood-brain barrier dysfunction in vitro and in vivo.Phytochemical antioxidants modulate mammalian cellular epigenome: implications in health and disease.Sildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variabilityVitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelinationEffects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease.Gsta4 Null Mouse Embryonic Fibroblasts Exhibit Enhanced Sensitivity to Oxidants: Role of 4-Hydroxynonenal in Oxidant Toxicity.Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.Reactive aldehydes--second messengers of free radicals in diabetes mellitus.The role of oxysterols in vascular ageing.Foam cell-derived 4-hydroxynonenal induces endothelial cell senescence in a TXNIP-dependent manner.Phospholipase D signaling mediates reactive oxygen species-induced lung endothelial barrier dysfunction.Phloretin ameliorates 2-chlorohexadecanal-mediated brain microvascular endothelial cell dysfunction in vitro.Covalent adduct formation between the plasmalogen-derived modification product 2-chlorohexadecanal and phloretin.Aspalatone Prevents VEGF-Induced Lipid Peroxidation, Migration, Tube Formation, and Dysfunction of Human Aortic Endothelial CellsThe Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy.
P2860
Q33790988-E1716E56-1B7B-4114-AE98-083DA741C2A8Q34731236-CEC953CB-D48A-4BF5-851B-CEC90B0CFB15Q35965132-8C8F89CC-B825-4AA9-A5A8-CD4611CDAF99Q36382353-A48B254D-BB9C-4984-8232-C0A910AB729BQ36773824-A6B1A8AE-D355-434B-8025-34861712B5D4Q37133517-B55D86ED-939A-4E3A-967A-4428B1FC5744Q37394472-61EC8B46-3DF3-4E2C-B19C-8FFF618F9DF9Q37699846-35A1273E-47EC-45B3-B42C-4C08B63423E1Q38092186-6E5293E0-83ED-4BDF-8B21-2A276136A7D9Q38663222-6EAB5CFD-CD4C-4CED-8F7B-A4FE7B31BDB1Q38901888-E493F956-0250-4F5C-AE66-D916BFDE162EQ40302478-A0CEF602-84BC-4914-8C5D-C1ACF6C56B4DQ41596971-1C704166-48D3-41A5-9137-B6838AE869DAQ41598092-4462F3B7-F134-4084-B07B-5C1AA051FFECQ42323537-EA0C2D89-6D96-42C6-9241-C47A942CE7BCQ43375909-C7D1842D-B062-42C6-B683-EB3027B45E22
P2860
Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hydroxyalkenals and oxidized p ...... endothelial barrier function.
@ast
Hydroxyalkenals and oxidized p ...... endothelial barrier function.
@en
type
label
Hydroxyalkenals and oxidized p ...... endothelial barrier function.
@ast
Hydroxyalkenals and oxidized p ...... endothelial barrier function.
@en
prefLabel
Hydroxyalkenals and oxidized p ...... endothelial barrier function.
@ast
Hydroxyalkenals and oxidized p ...... endothelial barrier function.
@en
P2860
P1476
Hydroxyalkenals and oxidized p ...... endothelial barrier function.
@en
P2093
Peter V Usatyuk
Viswanathan Natarajan
P2860
P356
10.1016/J.MVR.2011.04.012
P577
2011-05-06T00:00:00Z